1Kassebaum N J, Bertozzi -Villa A, Coggeshall MS, et al. Global, regional, and National levels and causes of maternal mortality during 1990 -2013: a systematic analysis for the Global Burden of Disease Study 2013 [ J]. Lancet, 2014, 384 (9947) : 980 - 1004.
2Mehrabadi A, LIU Shiliang, Bartholomew S, et al. Temporal trends in postpartum hemorrhage and severe postpartum hemorrhage in Canada from 2003 to 2010 [ J ]. J Obstet Gynaecol Can, 2014, 36(1) : 21 -33.
3Antony KM, Dildy GA. Postpartum hemorrhage : the role of the Maternal- Fetal Medicine specialist in enhancing quality and patient safety [ J ]. Semin Perinatol, 2013, 37 (4) : 246 - 256.
4Nebout S, Merbai N, Faitot V, et al. Management of major postpartumhemorrhage[Jl; Presse Med, 2014, 43 (2): 111 -117.
5MOUSA Hatem - a, Blum J, Abou El Senoun G, et al. Treatment for primary postpartum haemorrhage [J] . Cochrane Database Syst Rev, 2014, 2: CD003249.
6Arrowsmith S, Wray S. Oxytocin: its mechanism of action and receptor signalling in the myometrium [ J ] J Neuroendocrinol, 2014, 26(6) : 356 -369.
8Westhoff G, Cotter AM, Tolosa JE. Prophylactic oxytocin for the third stage of Labour to prevent postpartum haemorrhage [J]. Cochrane Database Syst Rev, 2013, 10: CD001808.
4Elbourne DR, Prendiville WJ, Carroli G, et al. Prophylactic use of oxytocin in the third stage of labour [ J ]. Coch Datab Syst Rev, 2001, (4) :CD001808.
5Wedisinghe L, Macleod M, Murphy DJ. Use of oxytocin to prevent haemorrhage at caesarean section - A survey of practice in the United Kingdom [J]. Eur J Obstet Gynecol Reprod Biol, 2008,137( 1 ) :27-30.
6Boucher M, Nimrod CA, Tawagi GF, et al. Comparison of carbetocin and oxytocin for the prevention of postpartum hemorrhage following vaginal delivery:a double-blind randomized trial[ J ]. J Obstet Gynaecol Can ,2004,26 (5) :481-488.
7Su LL, Chong YS, Samuel M. Oxytocin agonists for preventing postpartum haemorrhage [J]. Coeh Datab Syst Rev, 2007, 18 ( 3 ) : CD005457.
8Liabsuetrakul T, Choobun T, Peeyananjarassri K,et al. Prophylactic use of ergot alkaloids in the third stage of labour[ J]. Coch Datab Syst Rev,2007, 18(2) :CD005456.
9McDonald S, Abbott JM, Higgins SP. Prophylactic ergometfineoxytocin versus oxytocin for the third stage of labour [ J ]. Coch Datab Syst Rev, 2004, (1) :CD000201.
10Lamont RF, Morgan D J, Logue M, et al. A prospective randomised trial to compare the efficacy and safety of hemabate and syntometrine for the prevention of primary postpartum haemorrhage [J]. Prostaglandins Other Lipid Mediat, 2001,66 ( 3 ) : 203- 210.
6Kassebaum NJ,Bertozzi-Villa A,CoggeshaU MS,et al. Global,regional,and National levels and causes of maternal mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet,2014,384 ( 9947):980-1004.
7Bai J, Sun Q, Zhai H. Comparison of oxytocin and carbo- prost tromethamine in the prevention of postpartum hem- orrhage in high-risk patients undergoing cesarean delivery [J]. Exp Ther Med, 2014,7( i ) : 46.
8Morey SS.ACOG releases report on risk factors, causes and management of postpartum hemorrhage[J]. Am Faro Phy- sician, 1998,58(4) : 1 002.
9Azar M, Jennifer AH, Lily L, et al. Trends in postpartum hemorrhage from 2000 to 2009 : a population-based study [J]. BMCPregnancy Childbirth,2012,11(12) : 108.
10Kassebaum NJ,Bertozzi-Villa A,Coggeshall MS,et al.Global,regional,and national levels and causes of maternal mortality during1990-2013:a systematic analysis for the Global Burden of Disease Study 2013[J].Lancet,2014,384(9947):980-1004.
